Compare Ascendis Pharma A/S (ASND) vs Dell Technologies Inc (DELL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ascendis Pharma A/S vs Dell Technologies Inc — how do they compare? Ascendis Pharma A/S trades at $253.76 (market cap $16.67B), while Dell Technologies Inc trades at $452.72 (market cap $284.93B). The key difference: Dell Technologies Inc is far larger — about 17.1× Ascendis Pharma A/S's market cap, and Dell Technologies Inc pays a 0.57% dividend while Ascendis Pharma A/S pays none. Which is the better fit depends on your goals.
| ASND | DELL | |
|---|---|---|
Market Cap | $16.67B | $284.93B |
Sector | Health | Technology |
52-Week High | $277.18 | $467.27 |
52-Week Low | $189.74 | $111.10 |
Enterprise Value | $17.04B | $304.51B |
Dividend Yield | — | 0.57% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Ascendis Pharma A/S
Ascendis Pharma A/S is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with significant unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates mainly in North America, Germany, China, and Denmark and derives the majority of its revenue from China.
Read more on ASND →About Dell Technologies Inc
VMware is an industry titan in virtualizing IT infrastructure and became a stand-alone entity after spinning off from Dell Technologies in November 2021. The software provider operates in the three segments: licenses
Read more on DELL →
